Advertisement
OtherCARDIOVASCULAR PHARMACOLOGY

Identification of Low Molecular Weight GP IIb/IIIa Antagonists That Bind Preferentially to Activated Platelets

Rodney A. Bednar, S. Lee Gaul, Terence G. Hamill, Melissa S. Egbertson, Jules A. Shafer, George D. Hartman, Robert J. Gould and Bohumil Bednar
Journal of Pharmacology and Experimental Therapeutics June 1998, 285 (3) 1317-1326;
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherCARDIOVASCULAR PHARMACOLOGY

Identification of Low Molecular Weight GP IIb/IIIa Antagonists That Bind Preferentially to Activated Platelets

Rodney A. Bednar, S. Lee Gaul, Terence G. Hamill, Melissa S. Egbertson, Jules A. Shafer, George D. Hartman, Robert J. Gould and Bohumil Bednar
Journal of Pharmacology and Experimental Therapeutics June 1, 1998, 285 (3) 1317-1326;
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement